Similar articles

• Future therapy of the insulin-dependent diabetic patient--the implantable insulin delivery system.

  Schade DS, Eaton RP, Carlson GA, Bair RE, Gaona JI Jr, Love JT, Urenda RS, Spencer WJ. Schade DS, et al. Diabetes Care. 1981 Mar-Apr;4(2):319-24. doi: 10.2337/diacare.4.2.319. Diabetes Care. 1981. PMID: 7011750 No abstract available.
• Present and future expectations regarding insulin infusion systems.

  Marliss EB, Caron D, Albisser AM, Zinman B. Marliss EB, et al. Diabetes Care. 1981 Mar-Apr;4(2):325-7. doi: 10.2337/diacare.4.2.325. Diabetes Care. 1981. PMID: 7011751 No abstract available.
• Insulin-infusion pump for diabetes.

  Felig P, Tamborlane W, Sherwin RS, Genel M. Felig P, et al. N Engl J Med. 1979 Nov 1;301(18):1004-5. N Engl J Med. 1979. PMID: 492219 No abstract available.
• [Causes and the principles of treatment in insulin-dependent diabetes mellitus (type I)].

  Waldhäusl W. Waldhäusl W. Pol Tyg Lek. 1982 Dec 27;37(51-52):1591-4. Pol Tyg Lek. 1982. PMID: 6763993 Review. Polish. No abstract available.
• Intraperitoneal insulin infusion: treatment option for type 1 diabetes resulting in beneficial endocrine effects beyond glycaemia.

  van Dijk PR, Logtenberg SJ, Gans RO, Bilo HJ, Kleefstra N. van Dijk PR, et al. Clin Endocrinol (Oxf). 2014 Oct;81(4):488-97. doi: 10.1111/cen.12546. Epub 2014 Jul 28. Clin Endocrinol (Oxf). 2014. PMID: 25041605 Review.